Brevital Sodium

Brevital Sodium is a brand name of methohexital, approved by the FDA in the following formulation(s):

BREVITAL SODIUM (methohexital sodium - injectable; injection)

• 
  Manufacturer: JHP PHARMS
  
  Approved Prior to Jan 1, 1982
  
  Strength(s): 2.5GM/VIAL ^[RLD], 500MG/VIAL ^[RLD]

Has a generic version of Brevital Sodium been approved?

No. There is currently no therapeutically equivalent version of Brevital Sodium available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Brevital Sodium. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with Brevital Sodium.

See also...

• Brevital Sodium Consumer Information (Wolters Kluwer)
• Brevital Sodium Consumer Information (Cerner Multum)
• Methohexital Consumer Information (Wolters Kluwer)
• Methohexital Consumer Information (Cerner Multum)